De Volta ao Basico: PCSK9 como um Novo Alvo para o Receptor LDL

Corral, Pablo

De Volta ao Basico: PCSK9 como um Novo Alvo para o Receptor LDL / Back to Basics: PCSK9 as a New Target for the LDL Receptor

Corral, Pablo.

Corral, Pablo; Internal Medicine Institute. Lipid Section. Mar del Plata. AR

Arq. bras. cardiol ; 102(1): e5-1/2014. tab, graf

Article in Portuguese | LILACS | ID: lil-704051

Subject(s)

Humans; Atherosclerosis/therapy; LDL-Receptor Related Proteins/metabolism; Proprotein Convertases/metabolism; Proprotein Convertases/therapeutic use; Serine Endopeptidases/metabolism; Serine Endopeptidases/therapeutic use; Cholesterol, LDL/metabolism; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Polymorphism, Genetic; Proprotein Convertases/pharmacology; Risk Factors; Serine Endopeptidases/pharmacology

Aterosclerose; Atherosclerosis; PCSK9 Protein, human; PCSK9 Proteina humana; Polimorfismo genetico; Polymorphism, genetic; Receptors, LDL; Tendencias; Trends

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Serine Endopeptidases / LDL-Receptor Related Proteins / Proprotein Convertases / Atherosclerosis Type of study: Etiology study / Risk factors Limits: Humans Language: Portuguese Journal: Arq. bras. cardiol Journal subject: Cardiology Year: 2014 Type: Article Affiliation country: Argentina Institution/Affiliation country: Internal Medicine Institute/AR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google